オプションチェーンは、SOL Glb Invの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、SOL Glb Invの市場センチメントを評価します。.

SOL Glb Inv (OTC:SOLCF) 株価情報, オプションチェーン

SOL Global Investments Corp is a cannabis company with a focus on legal U.S. states. Its strategic investments and partnerships across cultivation, distribution and retail complement the company's R&D program with the University of Miami. It is also involved in Retail, Agriculture, Quick Service Restaurants & Hospitality, Media Technology & Gaming, Energy and New Age Wellness.

SOL GLOBAL INVTS CORP by Sol Global Invts Corp.

SOL Global Investments Corp

Wells Fargo analyst Roger Read maintains Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) with a Overweight and lowers the price target from $87 to $86.

News

Price Target

Analyst Ratings

SHEL

Wells Fargo Maintains Overweight on Shell, Lowers Price Target to $86

Roth MKM analyst Scott Fortune reiterates Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) with a Buy and maintains $70 price target.

Reiteration

Roth MKM Reiterates Buy on Turning Point Brands, Maintains $70 Price Target

Wells Fargo analyst Roger Read maintains Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) with a Overweight and lowers the price target from $186 to $182.

Wells Fargo Maintains Overweight on Marathon Petroleum, Lowers Price Target to $182

Constellation Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) shares are trading lower after the company reported nearly flat third-quarter sales of $2.46 billion, missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42909722/constellation-brands-reports-third-quarter-fiscal-2025-financial-results" rel="noreferrer noopener">consensus estimate of $2.53 billion</a>.
Net sales for the Beer segment increased 3% Y/Y to $2.03 billion, and Wine and Spirits declined 14% to $431.4 million. Shipment volume for Beer climbed 1.6%, while Wine and Spirits declined 16.4%.
Gross profit increased 1% to $1.28 billion, and the operating income slid 0.4% to $793 million. The operating margin for the quarter was 32.2%.
Comparable EPS of $3.25 missed the analyst <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus estimate of $3.31.</a>
The company generated year-to-date&nbsp;operating cash flow&nbsp;of&nbsp;$2.6 billion, a 9% increase, and&nbsp;free cash flow&nbsp;of&nbsp;$1.6 billion, a 13% growth.
Constellation Brands ended the quarter with $73.7 million in cash and equivalents as of November 30, 2024.
Constellation&#8217;s board declared a quarterly cash dividend of $1.01 per share, payable on February 21, to stockholders of record on February 7.
&#8220;While we continue to face the subdued spend and value seeking behaviors that emerged among legal drinking age consumers in Q2, our Beer Business delivered a sequential increase in our depletions growth rate in Q3,&#8221; said President and CEO Bill Newlands.
Guidance: Constellation Brands lowered FY25 net sales growth outlook to 2% &#8211; 5% <a target="_blank" href="https://ml.globenewswire.com/Resource/Download/709e6f44-1387-465b-848f-c4133db7b367" rel="noreferrer noopener">from 4% – 6%</a>. It also lowered Comparable EPS guidance to $13.40 &#8211; $13.80 from $13.60 – $13.80 against an estimate of $13.71.
Constellation Brands currently sees an operating cash flow of $2.9 billion – $3.1 billion and a <a href="https://www.benzinga.com/calendars/guidance">free cash flow of $1.6 billion – $1.8 billion.</a>
Price Action: STZ shares are trading lower by 4.46% at $209.50 in premarket on the last check Friday.
Photo: T. Schneider via Shutterstock

Earnings

Equities

Large Cap

Guidance

Movers

Trading Ideas

General

Beer Maker Constellation Brands' Q3 Sales Hit By Subdued Spending; Stock Slides

WIIM

ZNTL

Zentalis Pharmaceuticals shares are trading higher after the company announced that the FDA has granted Fast Track Designation to azenosertib for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Mercury General Corporation (the "Company," "Mercury" or "We") announced today its preliminary assessment of the impact of the recent wildfires in Southern California.
An extreme wind-driven wildfire event that began on January 7, 2025 has caused widespread damage across parts of Southern California. The wildfires continue to burn, and it will be some time before the Company has an estimate of the total losses caused by this event. Based on information available to date, we expect the losses to exceed our reinsurance retention level of $150 million.
The Company's reinsurance program provides $1,290 million of limits on a per occurrence basis after covered catastrophe losses exceed the Company's retention of $150 million. The Company's reinsurance program also provides coverage for assessments from the California FAIR plan. To the extent that losses are reinsured, the reinsurance program calls for reinstatements of limits to cover future events. If the full $1,290 million limits are used up, then the total reinstatement premium would be $101 million.

Mercury General Anticipates Wildfire Losses In Southern California To Surpass $150M Reinsurance Retention Level; Coverage Available Up To $1.29B With $101M Reinstatement Premium

NEOG

Neogen shares are trading lower after the company issued FY25 revenue guidance below estimates.

Wells Fargo analyst Edward Kelly maintains United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) with a Underweight and raises the price target from $23 to $25.

UNFI

Wells Fargo Maintains Underweight on United Natural Foods, Raises Price Target to $25

SYTA

Siyata Mobile shares are trading lower after the company announced that it has postponed its press conference.

Continues to make an impact in the municipal fleet market
Pioneer Power Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPSI#NASDAQ">PPSI</a>) ("Pioneer" or the "Company"), a leader in the design, manufacture, service and integration of distributed energy resources, power generation equipment and mobile electric vehicle ("EV") charging solutions, today announced it has received an order valued at $1.3 million from the City of Portland, Oregon ("Portland") for multiple e-Boost Mobile units through Graybar Electric ("Graybar"), a leading national electrical distribution company, as part of Graybar's OMNIA Partners program.

Contracts

PPSI

Pioneer Announces It Has Received An Order Valued At $1.3M From The City Of Portland, Oregon For Multiple e-Boost Mobile Units Through Graybar Electric

Walgreens Boots Alliance shares are trading higher after the company reported better-than-expected Q1 financial results.

Goosehead Insurance, Inc. ("Goosehead" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>), a rapidly growing independent personal lines insurance agency, today announced that its subsidiary, Goosehead Insurance Holdings, LLC, has closed on a $300 million term loan B and $75 million revolving credit facility. The term loan facility will bear interest at a rate of SOFR plus 3.50%. Proceeds from the new term loan agreement will be used to retire the Company's existing $93 million term loan, pay a one-time special dividend, and other general corporate purposes. The maturation date of the new term loan facility is January 8, 2032.
Today, Goosehead announced that on January 9, 2025, Goosehead Financial, LLC declared a special distribution of $175 million payable in cash on January 31, 2025 to holders of record of LLC Units, including Goosehead, as of the close of business on January 21, 2025.&nbsp; In addition, Goosehead announced today that on January 9, 2025, its board of directors declared a one-time special cash dividend of $5.91 per share of Class A common stock.&nbsp; The dividend will be payable in cash on January 31, 2025 to holders of record of Class A common stock as of the close of business on January 21, 2025.&nbsp; $1.22 of the special dividend will be funded by cash received by Goosehead from prior tax distributions from Goosehead Financial, LLC that are in excess of the corporate income taxes payable by Goosehead.&nbsp; The remaining $4.69 of the special dividend will be funded by the cash received by Goosehead from the distribution by Goosehead Financial, LLC.

Dividends

GSHD

Goosehead Insurance Announces New $300M Term Loan B and Declares A One-Time Special Dividend Of $5.91 Per Share

Legal

SPI Energy Enters Settlement Agreement With SINSIN, Resolving All Disputes Arising From Share Sale And Purchase Agreement Dated Sept. 6, 2014; Co. Will Pay €45M In Three Installments

Wells Fargo analyst Edward Kelly maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Overweight and raises the price target from $96 to $100.

Wells Fargo Maintains Overweight on Walmart, Raises Price Target to $100

Key Business Objectives and Milestones for 2025
Bitopertin: GlyT1 Inhibitor (Heme Synthesis Modulator)
Pursue development and global registration of bitopertin in erythropoietic protoporphyria (EPP), with the potential for accelerated approval in the U.S. using PPIX as surrogate endpoint
<ul>
<li>Provide update in Q1 2025 on design of confirmatory APOLLO trial and plans for NDA submission, following Type C meeting with FDA</li>
<li>Initiate global, confirmatory APOLLO trial by mid-2025</li>
<li>Obtain protocol assistance and feedback on regulatory path from EMA</li>
<li>Continue to advance pre-commercialization and launch preparation activities</li>
</ul>
DISC-0974: Anti-hemojuvelin Antibody (Hepcidin Suppression)
Pursue next stage of development of DISC-0974 for the treatment of anemia in myelofibrosis patients and generate additional data supporting activity and dose selection in CKD anemia
<ul>
<li>Progress ongoing phase 2 MF anemia trial with initial data expected H2 2025</li>
<li>Progress ongoing phase 1b CKD anemia trial with multiple-dose data expected H2 2025</li>
<li>Continue to develop scientific rationale for hepcidin suppression in other anemias &nbsp;</li>
</ul>
DISC-3405: Anti-TMPRSS6 Antibody (Hepcidin Induction)
Initiate phase 2 clinical trial of DISC-3405 in PV and broaden role of iron restriction in other indications
<ul>
<li>Plan to initiate phase 2 clinical trial of DISC-3405 in PV in H1 2025</li>
<li>Continued to develop scientific rationale for therapeutic iron restriction in sickle cell disease and other indications</li>
</ul>
Bitopertin, DISC-0974, and DISC-3405 are investigational agents and are not approved for use as therapies in any jurisdiction worldwide.

Biotech

IRON

Disc Medicine Announces Bitopertin, DISC-0974, DISC-3405 Development Milestones For 2025, Bitopertin Aims For Accelerated Approval In U.S. With PPIX Endpoint, APOLLO Trial By Mid-2025; DISC-0974 Phase 2 MF Anemia Data In H2 2025; DISC-3405 Phase 2 PV Trial In H1 2025; NDA Submission Updates In Q1 2025

MRSN

Mersana Therapeutics shares are trading lower. The company announced initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin.

"NRF—NVIDIA today announced the <a href="https://www.nvidia.com/en-us/ai-data-science/ai-workflows/retail-shopping-advisor/">NVIDIA AI Blueprint for retail shopping assistants</a>, a generative AI reference workflow designed to transform shopping experiences online and in stores.
The blueprint — built on the <a href="https://www.nvidia.com/en-us/data-center/products/ai-enterprise/">NVIDIA AI Enterprise</a> and <a href="https://www.nvidia.com/en-us/omniverse/">NVIDIA Omniverse</a>&#x2122; platforms — helps developers create AI-powered digital assistants that work alongside and support human workers. These digital assistants can deliver the expertise of a company's best sales associate, stylist or designer, elevating customer satisfaction and workforce efficiency.
Using <a href="https://www.nvidia.com/en-us/ai-data-science/products/nemo/">NVIDIA NeMo&#x2122; microservices</a> provided within the blueprint, these highly skilled AI shopping assistants can understand text- and image-based prompts, search for multiple items simultaneously, complete complicated tasks such as creating a travel wardrobe, and answer contextual questions like whether a product is waterproof.
Developers can use the Omniverse platform in conjunction with a spatial-scanning solution to enable AI agents to present products in physically accurate virtual environments. For example, customers looking to buy a couch could preview how the furniture would look in their own living room.
AI agents with advanced capabilities like these are designed to enhance customer experiences, drive higher conversion rates, lower product return rates and increase the average size of orders through highly intelligent, personalized suggestions of complementary products or upgrades.
"AI agents can elevate shopping experiences, turning what can be impersonal transactions into smarter, more enjoyable interactions," said Azita Martin, vice president of AI for retail, consumer packaged goods and quick-service restaurants at NVIDIA. "Shoppers everywhere want intelligent product recommendations, personalized interactions and lightning-fast response times. AI agents built using the NVIDIA AI Blueprint for retail shopping assistants can deliver this kind of exceptional, always-on service to every customer."
 "

Tech

NVDA

NVIDIA Announces Blueprint For AI Retail Shopping Assistants

Wells Fargo analyst Ike Boruchow maintains Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) with a Equal-Weight and raises the price target from $48 to $60.

URBN

Wells Fargo Maintains Equal-Weight on Urban Outfitters, Raises Price Target to $60

Motorola Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) has entered into a definitive agreement to acquire Theatro Labs, Inc. ("Theatro"), maker of AI and voice-powered communication and digital workflow software for frontline workers, based in Richardson, Texas.
Theatro's software-as-a-service platform, purposefully designed for frontline workers, provides a suite of collaboration applications that deliver information in real time to help improve their productivity and physical safety. Using conversational language through a wearable device, users can ask Theatro's AI voice assistant for guidance to assist customers, check inventory and pricing, and communicate with other team members. The technology can help accelerate employees' work processes and product knowledge.
Additionally, with frontline employee safety threats and theft incidents continuing to rise, Theatro enables employees to discreetly alert management and security teams when they feel unsafe directly through the wearable device, while the AI voice assistant can issue step-by-step safety and incident protocol guidance to help manage a response. Theatro's software also integrates with video security cameras to identify potential theft or safety threats, and proactively alert employees on the store floor.

Motorola Solutions To Acquire Theatro, Maker Of AI And Voice-Powered Communication; No Financial Terms Disclosed

Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $171.09, with a high estimate of $180.00 and a low estimate of $152.00. Highlighting a 2.38% decrease, the current average has fallen from the previous average price target of $175.27. 
<img src="https://www.benzinga.com/files/images/story/2025/1736517673_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Ross Stores is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Aneesha Sherman</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$165.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Robert Drbul</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$173.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Michael Binetti</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$177.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$152.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ross Stores. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Ross Stores compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Ross Stores's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Ross Stores's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ROST/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ross Stores analyst ratings.</a>
<h2>Discovering Ross Stores: A Closer Look</h2>
Ross Stores operates as an off-price apparel and accessories retailer with the majority of its sales derived from its Ross Dress for Less banner. The company opportunistically procures excess brand-name merchandise made available via manufacturing overruns and retail liquidation sales at a 20%-60% discount to full prices. As such, its stores are often filled with a vast array of stock-keeping units, each with minimal product depth that creates a treasure hunt shopping experience. The firm's more than 1,750 Ross Dress for Less stores are primarily located in densely populated suburban communities and typically serve middle-income consumers. Ross also operates about 350 DD's Discounts chains targeting lower-income shoppers.
<h3>Understanding the Numbers: Ross Stores's Finances</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Ross Stores's revenue growth over a period of 3 months has been noteworthy. As of 31 October, 2024, the company achieved a revenue growth rate of approximately 2.97%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Ross Stores's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.64%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Ross Stores's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.41% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Ross Stores's ROA excels beyond industry benchmarks, reaching 3.3%. This signifies efficient management of assets and strong financial health.
Debt Management: Ross Stores's debt-to-equity ratio is below the industry average at 1.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ROST

Assessing Ross Stores: Insights From 11 Financial Analysts

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has successfully raised CAD 3.6 million through a brokered private ...

SOL Global Completes CAD 3.6M Fundraising Effort

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has bolstered its confidence in the Solana ecosystem by investing a...

SOL Global Expands Investment in Solana Tokens

SOL Global acquires an additional $1.5M in solana tokens

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has introduced a new staking strategy aimed at boosting returns and...

SOL Global Unveils New Solana Staking Strategy

SOL Global announces Solana investment staking strategy

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has expanded its stake in the Solana ecosystem with a $1.5 million ...

SOL Global Boosts Investment in Solana Ecosystem

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has made a strategic move by repaying $3.4 million of its debt, red...

SOL Global's Financial Strategy and Debt Reduction

SOL Global announces loan repayment

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments is shifting its focus solely to the Solana ecosystem by divesting a...

SOL Global Refocuses on Solana with Strategic Shift

SOL Global Investments (TSE:SOL) has released an update. SOL Global Investments has successfully settled its debt totaling $9.6 million by issuing ...

Comments

SOL Glb Inv

SOL Glb Inv (SOLCF) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル